416PMeta of classical chemotherapy compared with high-dose chemotherapy combined with autologous stem cell transplantation in newly diagnosed medulloblastoma patients after radiotherapy

ConclusionsHDCT+ASCR was not recommended for newly diagnosed high-risk MB patients. The clinical significance of HDCT+ASCR at the time of initiation in the standard risk group remains to be further explored.Legal entity responsible for the studyThe Second Hospital of Hebei Medical University.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research